Skip to main content

ERRATUM article

Front. Endocrinol., 10 March 2023
Sec. Diabetes: Molecular Mechanisms
Volume 14 - 2023 | https://doi.org/10.3389/fendo.2023.1172597

Erratum: Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology

  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology

By Memaj P and Jornayvaz FR (2022) Front. Endocrinol. 13:1031633. doi: 10.3389/fendo.2022.1031633

An omission to the funding section of the original article was made in error. The following sentence has been added: “Open access funding was provided by the University of Geneva”.

The original version of this article has been updated.

Keywords: NAFLD, type 1 diabetes, glycogenic hepatopathy, prevalence, pathophysiology

Citation: Frontiers Production Office (2023) Erratum: Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology. Front. Endocrinol. 14:1172597. doi: 10.3389/fendo.2023.1172597

Received: 23 February 2023; Accepted: 23 February 2023;
Published: 10 March 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

Download